Ademi LLP said it is investigating possible securities fraud claims against Cellebrite. The law firm said its review focuses on whether Cellebrite made inaccurate statements about its financial statements, business operations and prospects, and on recent disclosures that some U.S. federal and European government opportunities were encountering additional administrative and procurement requirements related to Cellebrite's foreign-entity status. The announcement invites potential participants to contact the firm for more information at no cost or obligation and was issued as attorney advertising.